Most of us think of statins as a heart-health drug. For years, that has been the story, lowering cholesterol and cutting the risk of heart attacks and strokes.
Now the eyes have entered the conversation.
People who took statins were about 15 percent less likely to develop open-angle glaucoma, the most common form of a disease that can quietly steal sight.
The finding comes from an observational study published October 6, 2026 in the British Journal of Ophthalmology.
Also read: Women who reach menopause early may carry a mental health burden that too often goes unrecognized
Researchers tracked health records from a global database of around 165 million people. They compared about 210,000 adults over 40 who had used statins between August 2006 and August 2026 with the same number of matched adults who had not.
At the five-year mark, 2.3 percent of statin users had been newly diagnosed with glaucoma. In the non-user group it was 2.6 percent. The gap sounds small, but across millions of people it adds up.
Less need for surgery and laser treatment
The second finding may be more striking. Among patients who already had glaucoma, statin users were less likely to need the stronger treatments doctors reach for when eye drops are not enough.
They had a 36 percent lower risk of incisional glaucoma surgery. The risk of selective laser trabeculoplasty, a laser procedure that improves fluid drainage inside the eye, fell by 60 percent.
Also read: Sleeping outside this window may raise your dementia risk by up to 28 percent
The risk of minimally invasive glaucoma surgery dropped by 55 percent. Even the chance of needing pressure-lowering eye drops was 12 percent lower. The benefits held when the researchers followed patients for ten years.
What the study can and cannot say
This is not proof. The authors call it an observational study, meaning they looked at what already happened to people in records, not at a trial where some patients were given statins and others a dummy pill.
Statin users may differ from non-users in ways the data cannot show. They may visit doctors more often, follow medical advice more closely, or lead different lives. The team also lacked each patient's eye pressure readings.
Prospective randomized trials are needed before doctors would recommend statins specifically to protect vision.
Also read: This is the healthiest way to cook eggs for your heart
Why glaucoma matters
About 80 million people worldwide have glaucoma, including more than three million Americans, according to the Glaucoma Research Foundation.
Roughly half of them do not know, because the vision loss usually creeps in from the edges without pain.
The findings add to a growing list of possible non-cardiovascular effects for statins. Research has also linked early statin use to a lower risk of dementia in people with type 2 diabetes.
Anyone with a family history of glaucoma, or who notices patches of lost vision at the edges of their sight, should book an eye exam.
Also read: Halloween candy ranked: Which sweets damage your teeth most?
The disease often shows up with subtle warning signs that are easy to miss until the damage is already done.
Also read: One number on your blood test may cut your heart attack risk in half
This article is made and published by Mie Hermansen, who may have used AI in the preparation.